Innovation Act Stalls in the House

iStock_000001499158_SmallRepresentative Goodlatte’s Innovation Act (H.R. 9) has been shelved for now, and will not receive a floor vote until September at the earlier. There is significant conflict between measures intended to deter patent trolls and the ability of non-profit institutional NPE’s to enforce their patents. Big Pharma wants “out” of IPR entirely.  Action on the corresponding Senate Bill,  S. 1137, will also be postponed.

A 3-page chart comparing major provisions of the bill with IPO positions is available on the IPO website. 

This entry was posted in Patent Reform Legislation and tagged , , , , , , . Bookmark the permalink.

One Response to Innovation Act Stalls in the House

  1. Something in the world of PatentFreedoms needs some “Innovation” for sure.

Leave a Reply

Your email address will not be published. Required fields are marked *